首页> International journal of cardiology> In vivo effect of LASSBio-785, a lipid-lowering and anti-inflammatory agent, on cardiac Ca(2+)-ATPases from hypercholesterolemic rats.

In vivo effect of LASSBio-785, a lipid-lowering and anti-inflammatory agent, on cardiac Ca(2+)-ATPases from hypercholesterolemic rats.

导出 LinkOut

翻译打印收藏纠错

第一作者： Emiliana B,Marques

第一单位： Laboratory of Experimental Pharmacology, Department of Physiology and Pharmacology, Fluminense Federal University, Niterói, RJ, Brazil.

作者： Emiliana B,Marques ^[1] ; Nádia A V,Motta ^[1] ; Arthur E,Kummerle ^[2] ; Carlos A M,Fraga ^[3] ; Eliezer J,Barreiro ^[3] ; Fernanda C F,Brito ^[1] ; Christianne B V,Scaramello ^[4]

作者单位： Laboratory of Experimental Pharmacology, Department of Physiology and Pharmacology, Fluminense Federal University, Niterói, RJ, Brazil. ^[1] Department of Chemistry, Institute of Exact Sciences, Rural Federal University of Rio de Janeiro UFRRJ, Seropédica, R.J., Brazil. ^[2] Laboratory of Evaluation and Synthesis of Bioactive Compounds (LASSBio), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, R.J., Brazil. ^[3] Laboratory of Experimental Pharmacology, Department of Physiology and Pharmacology, Fluminense Federal University, Niterói, RJ, Brazil. Electronic address: christiannebretas@vm.uff.br. ^[4]

关键词 Anti-inflammatory agents Ca(2+)-ATPase Hypolipidemic agents LASSBio-785 N-acylhydrazone derivative